申请人:RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.
公开号:EP0151094A2
公开(公告)日:1985-08-07
New imidazopyridine derivatives are described, having the following formula:
wherein R represents a hydrogen atom, an alkyl radical of 1 to 3 carbon atoms, a methoxy group or a halogen atom,
R1 represents a hydrogen atom, an alkyl radical of 1 to 3 carbon atoms,
n represents an integer of 1 to 10,
X represents a non-toxic pharmaceutically acceptable ion, which possess a skeletal muscle paralysing activity.
所述的新型咪唑吡啶衍生物具有下式:其中 R 代表氢原子、1 至 3 个碳原子的烷基、甲氧基或卤素原子,R1 代表氢原子、1 至 3 个碳原子的烷基,n 代表 1 至 10 的整数,X 代表无毒的药学上可接受的离子,具有骨骼肌麻痹活性。